<DOC>
	<DOCNO>NCT00801450</DOCNO>
	<brief_summary>Triamcinolone already use different route administration treat diabetic macular edema . In present study , intravitreal injection ( IVI ) posterior sub-Tenon 's infusion ( STI ) triamcinolone acetonide ( TA ) phacoemulsification cataract surgery eye refractory diffuse diabetic macular edema test .</brief_summary>
	<brief_title>Intravitreal Injection Versus Sub-Tenon 's Infusion Triamcinolone Acetonide Refractory Diabetic Macular Edema During Cataract Surgery</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Refractory diffuse DME unresponsive focal laser photocoagulation Best correct visual acuity 20/800 20/40 ; Central subfield macular thickness great 300 Âµm Previous ocular surgery Glycosylated hemoglobin ( Hb A1C ) rate 10 % History glaucoma ocular hypertension Loss vision result cause Systemic corticoid therapy Severe systemic disease Any condition affect followup documentation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>diabetes</keyword>
	<keyword>macular edema</keyword>
	<keyword>triamcinolone</keyword>
	<keyword>cataract</keyword>
	<keyword>refractory diabetic macular edema</keyword>
</DOC>